1259556-47-2

Upstream product

• 1259556-29-0 1-[4-{(5R)-azidomethyl-2-oxo-oxazolidin-3-yl}-phenyl]-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester 
• 1259556-27-8 1-[4-((5R)-hydroxymethyl-2-oxooxazolidin-3-yl)phenyl]-3-azabicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester 
• 1259556-22-3 [2-aminomethyl-2-(4-bromo-phenyl)-cyclopropyl]-methanol 
• 1259556-21-2 1-(4-bromo-phenyl)-2-hydroxymethyl-cyclopropanecarbonitrile 
• 1259556-28-9 1-[4-{(5R)-methanesulfonyloxymethyl-2-oxo-oxazolidin-3-yl}-phenyl]-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester 
• 1259556-26-7 1-(4-benzyloxycarbonylamino-phenyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester 
• 927812-93-9 tert-butyl 1-(4-aminophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate 
• 1259556-25-6 1-(4-benzylamino-phenyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester 
• 863679-83-8 tert-butyl 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate 
• 86215-40-9 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane 
• 16532-79-9 4-Bromophenylacetonitrile 

Downstream Products

• 1259556-48-3 1-{4-[5(S)-(methoxycarbonylamino-methyl)-2-oxo-oxazolidin-3-yl]-phenyl}-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester 
• 1259553-79-1 1-{4-[5(S)-(methoxycarbonylamino-methyl)-2-oxo-oxazolidin-3-yl]-phenyl}-3-aza-bicyclo[3.1.0]-hexane-3-carboxylic acid methyl ester 

Relevant academic research and scientific papers

NOVEL AZABICYCLOHEXANES

The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.

NOVEL AZABICYCLOHEXANES

The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.